What: Smothered in snow-white flowers, Pieris japonica “White Cascade” is a herald of spring. When in full bloom, one can hardly see the delicate evergreen foliage hidden beneath the trusses ...

What: Pieris japonica “Brookside Miniature” is a dwarf columnar lily-of-the-valley shrub with all great qualities of its larger siblings. In late winter to early spring, clusters of urn-shaped ...

Olfactory learning in Pieris brassicae butterflies is dependent on the intensity of a plant-derived oviposition cue ...

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) shareholders will doubtless be very grateful to see the share price up 72% in the last quarter. But will that repair the damage for the weary investors ...

With so many partnerships and several drugs in the pipeline that target multi-billion dollar markets, I believe that Pieris is a good speculative biotech to look into.

Pieris (PIRS) announces strategic update after partner AstraZeneca terminated collaboration agreement and returned the rights to elarekibep.

Servier will partner with Pieris Pharmaceuticals to co-develop Pieris’ preclinical dual-checkpoint inhibitor PRS-332 and up to seven other immuno-oncology bispecific drug candidates in a ...

Pieris Pharmaceuticals Inc PIRS announced that partner AstraZeneca plc AZN decided to discontinue and cease dosing in the ongoing clinical studies of elarekibep, an inhaled IL-4 receptor alpha ...

Investors might want to bet on Pieris Pharmaceuticals (PIRS), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...